Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 29 clinical trials
featured
ENSURE-AF

ENSURE-AF

  • 62 views
  • 25 Mar, 2021
  • 1 location
Comparison of Two Doses of Enoxaparin for Thromboprophylaxis in Hospitalized COVID-19 Patients

The purpose of this study is to determine whether a higher dose of low molecular weight heparin (enoxaparin 40 mg b.i.d.) is superior than the standard prophylaxis dose (enoxaparin 40 mg o.d

enoxaparin
  • 0 views
  • 29 Jan, 2021
  • 1 location
Prevention of Venous Thromboembolism in Patients With Acute Primary Intracerebral Hemorrhage

- To evaluate the efficacy of using IPC during the acute phase of ICH in the prevention of VTE. - To assess the safety and efficacy of additional therapy with enoxaparin

  • 13 views
  • 07 Nov, 2020
  • 1 location
Enoxaparin for Primary Thromboprophylaxis in Ambulatory Patients With COVID-19

The OVID study will show whether prophylactic-dose enoxaparin improves survival and reduces unplanned hospitalizations in ambulatory patients aged 50 or older diagnosed with COVID-19, a novel

cough
dyspnea
SARS
respiratory symptom
pharyngitis
  • 0 views
  • 02 May, 2021
  • 7 locations
Lovenox 30 mg Twice Daily (BID) Versus 40 mg Once Daily (QD)

The risk of developing a blood clot occurs in up to 60% of all critical care patients. Many times enoxaparin (or Lovenox) is given to patients who are at a higher risk of developing clots in

critical illness
lovenox
blood clot
clot
enoxaparin
  • 10 views
  • 18 Mar, 2021
  • 1 location
PREVENTion of Clot in Orthopaedic Trauma

The purpose of this study is to compare aspirin versus low-molecular weight heparin (LMWH) (Enoxaparin) as a thromboprophylaxis in patients who sustain a fracture.

blood clot
clot
heparin
aspirin
enoxaparin
  • 52 views
  • 04 Feb, 2021
  • 20 locations
Early Prophylactic Low-molecular-weight Heparin (LMWH) in Symptomatic COVID-19 Positive Patients

, death. Enoxaparin is a blood-thinning drug which has been used by doctors and nurses in hospitals for many years to prevent the thickening of blood which may lead to a clot. It is easier for doctors to

  • 0 views
  • 27 Apr, 2021
  • 3 locations
Comparison of Anticoagulation Prolongation vs. no Anticoagulation in STEMI Patients After Primary PCI

anticoagulation prolongation by randomization, the subject will be assigned to UFH, enoxaparin or bivalirudin (same regimen allocated by centre) for at least 48 hours after PPCI. The results from this study are

heparin
enoxaparin
stemi
  • 0 views
  • 01 Feb, 2021
  • 1 location
Weight-Adjusted vs Fixed Low Doses of Low Molecular Weight Heparin For Venous Thromboembolism Prevention in COVID-19

standard prophylactic dose (eg. Enoxaparin 4000IU once daily) could be insufficient in obese patients and VTE has been reported in patients treated with a standard prophylactic dose. In COVID-19

SARS
enoxaparin
venous thromboembolism
covid-19
pneumonia
  • 7 views
  • 27 Jan, 2021
  • 18 locations
FREEDOM COVID-19 Anticoagulation Strategy

Coronavirus Disease (COVID-19), caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has led to unprecedented morbidity and mortality in the modern era. To date, nearly 13 million people have contracted COVID-19, leading to more than 550,000 deaths worldwide. As the number of affected individuals continues to climb, effective strategies for …

oximetry
acute respiratory distress
SARS
enoxaparin
fever
  • 20 views
  • 19 Feb, 2021
  • 20 locations